- call +1-201-465-4211
- email sales@mrinsights.biz
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
Scope of the Report:
This report studies the Multiplexed Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Multiplexed Diagnostics market by product type and applications/end industries.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
The global Multiplexed Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Multiplexed Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Agilent Technologies
Bio-Rad Laboratories, Inc.
BioMerieux SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Luminex Corporation
Hologic, Inc.
Thermo Fisher Scientific, Inc.
Siemens Healthineers
Abbott Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Very High Density Multiplexed Assays (> 10,000-plex)
High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
Medium Density Multiplexed Assays (plex < 500)
Low Density Multiplexed Assays (plex ≤ 5)
Next Generation Sequencing Assays
Market Segment by Applications, can be divided into
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Multiplexed Diagnostics Market Overview
1.1 Product Overview and Scope of Multiplexed Diagnostics
1.2 Classification of Multiplexed Diagnostics by Types
1.2.1 Global Multiplexed Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Multiplexed Diagnostics Revenue Market Share by Types in 2017
1.2.3 Very High Density Multiplexed Assays (> 10,000-plex)
1.2.4 High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
1.2.5 Medium Density Multiplexed Assays (plex < 500)
1.2.6 Low Density Multiplexed Assays (plex ≤ 5)
1.2.7 Next Generation Sequencing Assays
1.3 Global Multiplexed Diagnostics Market by Application
1.3.1 Global Multiplexed Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Academic Research Institutes
1.3.3 Hospital
1.3.4 Pharmaceutical Companies
1.3.5 Clinical Research Organizations
1.3.6 Diagnostic Laboratories
1.4 Global Multiplexed Diagnostics Market by Regions
1.4.1 Global Multiplexed Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Multiplexed Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Multiplexed Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Multiplexed Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Multiplexed Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Multiplexed Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Multiplexed Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Agilent Technologies
2.1.1 Business Overview
2.1.2 Multiplexed Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technologies Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bio-Rad Laboratories, Inc.
2.2.1 Business Overview
2.2.2 Multiplexed Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioMerieux SA
2.3.1 Business Overview
2.3.2 Multiplexed Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux SA Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 Business Overview
2.4.2 Multiplexed Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Illumina, Inc.
2.5.1 Business Overview
2.5.2 Multiplexed Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Illumina, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Luminex Corporation
2.6.1 Business Overview
2.6.2 Multiplexed Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Luminex Corporation Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hologic, Inc.
2.7.1 Business Overview
2.7.2 Multiplexed Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hologic, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Business Overview
2.8.2 Multiplexed Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Siemens Healthineers
2.9.1 Business Overview
2.9.2 Multiplexed Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Siemens Healthineers Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Abbott Laboratories
2.10.1 Business Overview
2.10.2 Multiplexed Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Abbott Laboratories Multiplexed Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Multiplexed Diagnostics Market Competition, by Players
3.1 Global Multiplexed Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Multiplexed Diagnostics Players Market Share
3.2.2 Top 10 Multiplexed Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Multiplexed Diagnostics Market Size by Regions
4.1 Global Multiplexed Diagnostics Revenue and Market Share by Regions
4.2 North America Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Multiplexed Diagnostics Revenue by Countries
5.1 North America Multiplexed Diagnostics Revenue by Countries (2013-2018)
5.2 USA Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Multiplexed Diagnostics Revenue by Countries
6.1 Europe Multiplexed Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Multiplexed Diagnostics Revenue by Countries
7.1 Asia-Pacific Multiplexed Diagnostics Revenue by Countries (2013-2018)
7.2 China Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Multiplexed Diagnostics Revenue by Countries
8.1 South America Multiplexed Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Multiplexed Diagnostics by Countries
9.1 Middle East and Africa Multiplexed Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Multiplexed Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Multiplexed Diagnostics Market Segment by Type
10.1 Global Multiplexed Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Multiplexed Diagnostics Market Forecast by Type (2018-2023)
10.3 Very High Density Multiplexed Assays (> 10,000-plex) Revenue Growth Rate (2013-2023)
10.4 High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) Revenue Growth Rate (2013-2023)
10.5 Medium Density Multiplexed Assays (plex < 500) Revenue Growth Rate (2013-2023)
10.6 Low Density Multiplexed Assays (plex ≤ 5) Revenue Growth Rate (2013-2023)
10.7 Next Generation Sequencing Assays Revenue Growth Rate (2013-2023)
11 Global Multiplexed Diagnostics Market Segment by Application
11.1 Global Multiplexed Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Multiplexed Diagnostics Market Forecast by Application (2018-2023)
11.3 Academic Research Institutes Revenue Growth (2013-2018)
11.4 Hospital Revenue Growth (2013-2018)
11.5 Pharmaceutical Companies Revenue Growth (2013-2018)
11.6 Clinical Research Organizations Revenue Growth (2013-2018)
11.7 Diagnostic Laboratories Revenue Growth (2013-2018)
12 Global Multiplexed Diagnostics Market Size Forecast (2018-2023)
12.1 Global Multiplexed Diagnostics Market Size Forecast (2018-2023)
12.2 Global Multiplexed Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Multiplexed Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Multiplexed Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Multiplexed Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Multiplexed Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Multiplexed Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Multiplexed Diagnostics Picture
Table Product Specifications of Multiplexed Diagnostics
Table Global Multiplexed Diagnostics and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
